Western blot banding patterns of HIV rapid progressors in the U.S. Navy Seropositive Cohort: Implications for vaccine development

Annals of Epidemiology

Volumn 6, Issue 4, 1996, Pages 341-347

  Garland, Frank C ^a,c   Garland, Cedric F ^b   Gorham, Edward D ^a   Brodine, Stephanie K ^a   Tauber, William B ^d   Daniell, F D ^d   Oldfield III, Edward C ^d   Carl, Mitchell ^d   Weiss, Peter ^d   Paperello, Scott ^d   Malone, John ^d   Malone, Joseph ^d   Wallace, Mark ^d   Zajdowicz, Thaddeus ^d   Zajdowicz, Margan ^d   Kennedy, Charles ^d   Olson, Patrick ^d   Hall, F Wesley ^d   Garst, Paul ^d   Newton, Berry ^d   Fallon, Ann ^d   more..

^a Epidemiol Div Nav Hlth Res C   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d NONE

Author keywords

AIDS vaccines; CD4+ lymphocyte count; cohort studies; HIV antibodies; Human immunodeficiency virus; Western blotting

Indexed keywords

VIRUS PROTEIN; VIRUS VACCINE;

ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; LYMPHOCYTE COUNT; MALE; NAVY; NORMAL HUMAN; PRIORITY JOURNAL; SERODIAGNOSIS; UNITED STATES; VACCINATION;

EID: 0030198373     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(96)00053-1     Document Type: Article

References (44)

1. 1. deGruttola N, Lange N, Dafni U. Modeling the progression of HIV infection. J Am Stat Assoc. 1991;86:569-577.
2. 2. Lang W, Perkins H, Anderson R, Royce R, Jewell N, Winkelstein, Jr W. Patterns of T-lymphocyte changes with Human Immunodeficiency Virus infection: from seroconversion to the development of AIDS. J AIDS. 1989;2:63-69.
3. 3. Longini I, Clark W, Byers R, et al. Statistical analysis of the stages of HIV infection using a Markov model. Stat Med. 1989;8:831-843.
4. 4. Longini I, Clark W, Gardner L, Brundage J. The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: A Markov modeling approach. J AIDS. 1991;4:1141-1147.
5. 5. Taylor J, Fahey J, Detels R, Giorgi J. CD4 percentage, CD4 number, and CD4:CD8 ratio in infection: Which to choose and how to use. J AIDS. 1989;2:114-124.
6. 6. Fahey J, Taylor J, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990;322:166-172.
7. 7. Saah A, Farzadegan H, Fox R, et al. Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol. 1987;25:1605-1610.
8. 8. Tsoukas C, Bernard N. Markers predicting progression of human immunodeficiency virus-related disease. Clin Microbiol Rev. 1994;7:14-28.
9. 9. Goedert J, Kessler C, Aledort L, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med. 1989;321:1141-1148.
10. 10. Schüpbach J, Popovic M, Gilden R, Gonda M, Sarngadharan M, Gallo R. Serological analysis of a subgroup of human T-lymphotropic retroviruses, HTLV-III, associated with AIDS. Science. 1984;224: 503-505.
11. 11. Samgadharan M, Popovic M, Bruch L, Schupbach J, Gallo R. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984;224:506-508.
12. 12. Burke D, Brundage J, Herbold J, et al. Human immunodeficiency virus infections among civilian applicants for United States military service, October 1985 to March 1986: Demographic factors associated with seropositivity. N Engl J Med 1987;317:131-136.
13. 13. Mawle A, McDougal J. Immunological aspects of human immunodeficiency virus infection. In: Schochetman G, George J, eds. AIDS Testing: Methodology and Management Issues. New York: Springer-Verlag, 1992:30-47.
14. 14. Lange J, Coutinho R, Krone W, et al. Distinct IgG recognitional patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. Br Med J (Clin Res Ed). 1986;292:228-230.
15. 15. Gaines H, von Sydow M, Sonnerborg A, et al. Antibody response in primary human immunodeficiency virus infection. Lancet. 1987;1: 1249-1253.
16. 16. Lange J, Paul D, Huisman H, et al. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J (Clin Res Ed). 1986;293:1459-11462.
17. 17. Margolick J, Fauci A. Immunopathogenesis of the acquired immunodeficiency syndrome (AIDS). In: Cinader B, Miller R, eds. Progress in Immunology. V. 6. New York: Academic Press; 1986:949-960.
18. 18. Weber J, Clapham P, Weiss R, et al. Human immunodeficiency virus infection in two cohort of homosexual men: Neutralising sera and association of anti-gag antibody with prognosis. Lancet. 1987;1: 119-122.
19. 19. Nicholson J, Spira T, Aloisio C, et al. Serial determinations of HIV-1 titers in HIV-infected homosexual men: Association of rising titers with CD4 T cell depletion and progression to AIDS. AIDS Res Human Retroviruses. 1989;5:205-215.
20. 20. Fernandez-Cruz E, Desco M, Garcia-Montes M, Longo N, Gonzalez B, Zabay J. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users. AIDS. 1990;4:987-994.
21. 21. Fenouillet E, Blanes N, Coutellier A, Gluckman J, Relationship between anti-p24 antibody levels and p24 antigenemia in HIV-infected patients. AIDS Res Human Retroviruses. 1993; 9:1251-1255.
22. 22. Kageyama S, Kurimura T. Disappearance of anti-p17 correlates with successful isolation of human immunodeficiency virus and deterioration in clinical status. Int J STD AIDS. 1990;1:129-131.
23. 23. Garland F, Garland C, Gorham E, Brodine S, Weiss P, Navy HIV Working Group. Specific Western blot bands are associated with initial CD4+ lymphocyte counts in human immunodeficiency virus seroconverters. Ann Epidemiol. 1994;4:27-31.
24. 24. Hausler Jr W, Joseph J, DiSalvo A, Verma M, et al. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR. 1989;38(Suppl 7):1-7.
25. 25. Garland F, Mayers D, Hickey T, et al. Incidence of human immunodeficiency virus seroconversion in US Navy and Marine Corps personnel, 1986 through 1988, JAMA. 1989;262:3161-3165.
26. 26. Garland F, Gorham E, Cunnion S, et al. Decline in human immunodeficiency virus seropositivity and seroconversion in U.S. Navy enlisted personnel: 1986 to 1989. Am J Publ Health. 1992;82:581-584.
27. 27. Munoz A, Wang M, Bass S, et al. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men: Multicenter AIDS Cohort Study group. Am J Epidemiol. 1989;130:530-539.
28. 28. Gorham E, Garland F, Mayers D, et al. CD4+ lymphocyte counts within 24 months of human immunodeficiency virus seroconversion: Findings in the U.S. Navy and Marine Corps. Arch Int Med. 1993; 153:869-876.
29. 29. Weiss P, Brodine S, Goforth R, et al. Initial low CD4 lymphocyte counts in recent HIV infection and lack of association with identified co-infections. J Infect Dis. 1992;166:1149-1153.
30. 30. Goedert J, Biggar R, Weiss S, et al. Effect of T4 count and co-factors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA. 1987;257:331-334.
31. 31. Rickman W, Waxdal M, Monical C, et al. Department of the Army lymphocyte immunophenotyping quality assurance program. Clin Immunol Immunopathol. 1989;85-95.
32. 32. Rickman W, Monical C, Waxdal M. Improved precision in the enumeration of absolute numbers of lymphocyte phenotypes with long-term proficiency testing. Ann NY Acad Sci. 1993;677:53-58.
33. 33. Schechter M, Hogg R, Aylward B, Craib K, Le T, Montaner J. Higher socioeconomic status is associated with slower progression of HIV progression independent of access to health care. J Clin Epidemiol. 1994;47:59-67.
34. 34. Fleiss J. Statistical methods for rates and proportions. 2nd ed. New York: Wiley, 1981.
35. 35. Fisher R. Statistical methods for research workers. 14th ed. Edinburgh: Oliver and Boyd, 1970.
36. 36. Rothman K. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-46.
37. 37. Levy J, Kaminsky L, Morrow V, et al. Infection by the retrovirus associated with the acquired immunodeficiency syndrome: clinical, biological, and molecular features. Ann Intern Med. 1985;103: 694-699.
38. 38. Morrow W, Wharton M, Stricker R, et al. Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS associated retrovirus. Clin Immunol Immunopathol. 1986;40:515-524.
39. 39. Carini C, Mezzaroma I, Scano G, et al. Characterization of specific immune complexes in HIV-related disorders. Scand J Immunol. 1987;26:21-28.
40. 40. Von Sydow M, Gaines H, Sonnerborg A, Forsgren M, Pehrson P, Strannegard O. Antigen detect ion in primary HIV infection. Br Med J. 1988;296:238-240.
41. 41. Starcich B, Hahn B, Shaw G, et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell, 1986;45:637-648.
42. 42. Centers for Disease Control. 1992. Revised classification system for HIV infection and expanded AIDS surveillance case definition for adolescents and adults. Atlanta; GA: Centers for Disease Control and Prevention, 1992.
43. 43. Lilienfeld A, Lilienfeld D. Foundations of Epidemiology. 2nd ed. New-York: Oxford; 1980.
44. 44. Salk J. Prospects for the control of AIDS by immunizing seropositive individuals. Nature. 1987;327:473-476.